The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Systemic third generation allosteric STING agonist CRD3874-SI, a novel immunotherapy, in patients with advanced solid tumors: Results from a single-agent phase I study.
 
Ciara Kelly
Employment - Daichii Sankyo (I)
Stock and Other Ownership Interests - daichii sankyo (I)
Consulting or Advisory Role - Deciphera; Kartos Therapeutics; Natera; SERVIER
Speakers' Bureau - Deciphera
Research Funding - Amgen (Inst); Curadev (Inst); GlaxoSmithKline; IDRx (Inst); InhibRx (Inst); Kartos Therapeutics (Inst); Merck (Inst); Regeneron (Inst); Servier (Inst); xencor (Inst)
Travel, Accommodations, Expenses - Deciphera
 
Monali Banerjee
Employment - Curadev Pharma
Leadership - CU Optics
Research Funding - Curadev Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Curadev Pharma (Inst)
Travel, Accommodations, Expenses - Curadev Pharma
 
Reinhard von Roemeling
Consulting or Advisory Role - Curadev Pharma Inc
Travel, Accommodations, Expenses - Curadev Pharma Inc
 
Alan Ho
Honoraria - Horizon CME
Consulting or Advisory Role - AffyImmune Therapeutics; Cantor Fitzgerald; Day One Biopharmaceuticals; GlaxoSmithKline; Immunome; InhibRx; Johnson & Johnson/Janssen; National Cancer Institute; Pyxis; Remix Therapeutics; Rgenta Therapeutics; Takeda
Speakers' Bureau - Miami Cancer Research Center; Mt. Sinai; New York University (NYU); Northwell Health; Physicans' Education Resource
Research Funding - Astellas Pharma; AstraZeneca; Avacta Life Sciences; Ayala Pharmaceuticals; Bayer; Bayer; BioAtla; Bristol-Myers Squibb; Daiichi; Eisai; Genentech/Roche; Hookipa Biotech; Kura Oncology; Merck; Novartis; OncC4; Poseida; Remix Therapeutics; Rgenta; TILT Biotherapeutics; Verastem
Patents, Royalties, Other Intellectual Property - LESIONAL DOSIMETRY METHODS FOR TAILORING TARGETED RADIOTHERAPY IN
Travel, Accommodations, Expenses - Hookipa Pharma; Lepu Biopharma; Remix Therapeutics
Other Relationship - Hookipa Biotech; Lepu Biopharma
(OPTIONAL) Uncompensated Relationships - Alliance for Clinical Trials in Oncology; HPV Cancer Alliance; International Thyroid Oncology Group
 
Lauren Banks
Honoraria - Total Health Conferencing
Consulting or Advisory Role - Hoplite Healthcare
Patents, Royalties, Other Intellectual Property - I hold a patent on T cell receptors targeting the EWSR1-WT1 fusion in desmoplastic small round cell tumor.
Travel, Accommodations, Expenses - Immudex; Total Health
 
Ping Chi
Stock and Other Ownership Interests - ORIC Pharmaceuticals (I)
Consulting or Advisory Role - Deciphera; GlaxoSmithKline; NewBay Pharma
Research Funding - Deciphera (Inst); NewBay Pharma (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from ORIC (I)
Travel, Accommodations, Expenses - NewBay Pharma
 
Camron Clark
Employment - Baystate Health System (I); Memorial Sloan-Kettering Cancer Center
 
Mary Louise Keohan
No Relationships to Disclose
 
Robert Maki
Stock and Other Ownership Interests - PEEL Therapeutics
Consulting or Advisory Role - Boehringer Ingelheim; Deciphera; PEEL Therapeutics
Speakers' Bureau - MJH Life Sciences
Research Funding - Boehringer Ingelheim (Inst); Day One Biopharmaceuticals (Inst); Exelixis (Inst); Incyte (Inst); InhibRx (Inst); Merck (Inst); Seed Therapeutics (Inst); Stand up to Cancer (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - Stand up to Cancer
(OPTIONAL) Uncompensated Relationships - D. Fellows Fund; Fondazione Enrico Pallazzo
 
Sujana Movva
Honoraria - Deciphera
Consulting or Advisory Role - Genmab
Research Funding - Ascentage Pharma Group (Inst); Hutchison MediPharma (Inst); Jaz (Inst); Pfizer (Inst); PTC (Inst); TRACON Pharma (Inst); Trillium Therapeutics (Inst)
 
Kelly Schroeder
Employment - Flatiron Health
 
Robert Lefkowitz
No Relationships to Disclose
 
Li-Xuan Qin
Employment - Sironax (I)
Leadership - Sironax (I)
Stock and Other Ownership Interests - Sironax (I)
 
Phillip Wong
Patents, Royalties, Other Intellectual Property - Receive small annual royalty payments from the University of Washington for a monoclonal antibody that was developed during my graduate studies there.
 
Sandip Middya
Employment - Curadev Pharma
Research Funding - Curadev Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Curadev Pharma (Inst)
Travel, Accommodations, Expenses - Curadev Pharma (Inst)
 
Ritesh Shrivastava
Employment - Curadev Pharma
Research Funding - Curadev Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Curadev Pharma (Inst)
Travel, Accommodations, Expenses - Curadev Pharma
 
Dejani Chakraborty
Employment - Curadev Pharma
Research Funding - CanBas (Inst)
Patents, Royalties, Other Intellectual Property - Curadev Pharma (Inst)
Travel, Accommodations, Expenses - Curadev Pharma
 
Arjun Surya
Employment - Curadev Pharma
Leadership - Curadev Pharma
Stock and Other Ownership Interests - Curadev Pharma
Research Funding - Curadev Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Curadev Pharma (Inst)
Travel, Accommodations, Expenses - Curadev Pharma
 
William Tap
Leadership - AstraZeneca; Atropos; Avacta Life Sciences; Certis Oncology Solutions
Stock and Other Ownership Interests - Atropos; Certis Oncology Solutions
Consulting or Advisory Role - Aadi; Abbisko Therapeutics; Boehringer Ingelheim; Curadev; Daiichi Sankyo; Deciphera; EMD Serono; Ikena Oncology; inhibrx; Ipsen; Ratio; Recordati; SynOX
Research Funding - Avacta Life Sciences (Inst); BioAtla (Inst); Cogent Biosciences (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); servier (Inst); SpringWorks Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Companion Diagnostic for CDK4 inhibitors - 14/854,329; Enigma and CDH18 as companion Diagnostics for CDK4 inhibition – SKI2016-021-03
 
Sandra D'Angelo
Consulting or Advisory Role - AADi; Adaptimmune; GI Innovation; GlaxoSmithKline; Medendi; Nektar; Pfizer; Piper Sandler & Company; Rain Therapeutics; Ratio therapeutics; Replimune; Servier
Research Funding - Amgen; Bristol-Myers Squibb.; Deciphera; EMD Serono; Incyte; Merck; Nektar
Travel, Accommodations, Expenses - Adaptimmune
Other Relationship - Adaptimmune; GlaxoSmithKline; Merck; Nektar